Skip to Content

Invesco Advantage International R6 QMGIX

Medalist Rating as of | See Invesco Investment Hub
  • NAV / 1-Day Return 11.12  /  +0.36 %
  • Total Assets 32.5 Mil
  • Adj. Expense Ratio
    0.940%
  • Expense Ratio 0.940%
  • Distribution Fee Level High
  • Share Class Type Retirement, Large
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 5.30%
  • Turnover 196%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:23 PM GMT+0

Morningstar’s Analysis QMGIX

Will QMGIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Invesco Advantage International R6 to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings QMGIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 34.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Msci Eafe Lowvol Tr Swap (Leg A)

8.22 2.6 Mil

S&P Canada 60 Index Mar14

7.88 2.5 Mil

Canadian Dollar Mar24

7.66 2.4 Mil
Derivative

United States Treasury Bills 0%

4.83 1.5 Mil
Government

United States Treasury Bills 0%

4.35 1.4 Mil
Government

Msci Emerg Low Vol Tr Swap (Leg A)

3.52 1.1 Mil

Futures Cash Collateral & Vm

3.37 1.1 Mil
Cash and Equivalents

Novo Nordisk A/S Class B

2.68 837,021
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd ADR

2.57 801,338
Technology

Novartis AG Registered Shares

2.56 798,327
Healthcare